UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
KUMC mulls bio-health investment
Korea University Medical Center said Thursday it would shift its growth str...
by Nam Doo-hyun
|
2018-02-22 11:36
라인
‘Gilead Sciences Korea won’t mind sales setback’
“As Gilead Sciences pursues cure of all diseases, I wouldn’t mind sales dec...
by Nam Doo-hyun
|
2018-02-21 15:42
라인
‘Psoriasis treatment Taltz outperforms rivals’
Lilly Korea’s biological agent Taltz (ingredient: ixekizumab) used as psori...
by Nam Doo-hyun
|
2018-02-21 11:37
라인
Cell therapy Rosmir to target anti-wrinkle market
Tego Science reportedly plans to release its cell therapy Rosmir to treat u...
by Nam Doo-hyun
|
2018-02-20 15:19
라인
‘Novo Nordisk Korea has no plan to downsize’
Multinational pharmaceutical companies have recently struggled over labor d...
by Nam Doo-hyun
|
2018-02-13 15:46
라인
Safer, more potent new drugs coming up this year
Multinational pharmaceutical giants are getting ready to release new drugs ...
by Nam Doo-hyun
|
2018-02-12 15:54
라인
‘New combo may become standard soft tissue sarcoma treatment’
With Lilly Korea’s Lartruvo (ingredient: olaratumab) obtaining insurance be...
by Nam Doo-hyun
|
2018-02-09 15:50
라인
Immunotherapies claims rose on insurance coverage in 2017
More health insurance coverage for expensive immunotherapies caused claims ...
by Nam Doo-hyun
|
2018-02-07 11:07
라인
Korea’s drug exports increased fastest to China in 2017
South Korea’s drug exports rose fastest to China last year, and medical dev...
by Nam Doo-hyun
|
2018-02-05 14:36
라인
Will new KRPIA head back US pharma in FTA revision?
There has been much gossip about reasons MSD Korea CEO Avi BenShoshan becam...
by Nam Doo-hyun
|
2018-02-02 14:53
라인
Overheated DHP Korea stocks face short-term trade limit
DHP Korea, a manufacturer of eye drops and other ophthalmic agents, faced a...
by Nam Doo-hyun
|
2018-01-31 15:34
라인
Contrast medium market shrank last year
Sales of contrast medium products went down in the domestic market last yea...
by Nam Doo-hyun
|
2018-01-24 15:14
라인
Antihypertensive, antiarteriosclerotic drugs surged last year
Prescription sales of antihypertensive drugs and antiarteriosclerotic treat...
by Nam Doo-hyun
|
2018-01-22 11:35
라인
Which certificates do you need for 4th industrial revolution?
A medical 3D printing technician, a Big Data analyst, and an artificial int...
by Nam Doo-hyun
|
2018-01-18 12:18
라인
Shares of ‘Celltrion trio’ plummet on profit-taking
Shares of Celltrion and its two affiliated firms plunged on Wednesday, and ...
by Nam Doo-hyun
|
2018-01-18 11:10
라인
‘Risk-sharing agreements improved access to expensive drugs’
As the reevaluation nears for drugs approved under risk-sharing agreements ...
by Nam Doo-hyun
|
2018-01-17 16:15
라인
Korea’s pharmaceutical exports up 20% in 2017
South Korea’s exports of pharmaceutical products expanded 20 percent in 201...
by Nam Doo-hyun
|
2018-01-16 11:21
라인
Shares of eye drops/masks makers rise on fine dust measure
Shares of manufacturers of eye drops and masks have risen on Monday, with t...
by Nam Doo-hyun
|
2018-01-15 15:48
라인
'Postmenopausal use of aromatase inhibitor ups fracture risk’
The postmenopausal use of aromatase inhibitor (AI) on breast cancer patient...
by Nam Doo-hyun
|
2018-01-15 14:42
라인
Gaucher disease drug effective for retention, early treatment, Sanofi says
Sanofi Genzyme emphasized the convenience of Cerdelga (Ingredient: eligusta...
by Nam Doo-hyun
|
2018-01-15 10:27
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top